China Pharma (CPHI) vs Incannex Healthcare (IXHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
China Pharma (CPHI) has outperformed Incannex Healthcare (IXHL) over the past year, losing 56.6% versus a loss of 75.8%. Incannex Healthcare is the larger company by market cap ($39.5 million vs $39.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | IXHL |
|---|---|---|
| Share price | $0.914 | $3.15 |
| Market cap | $39.32M | $39.49M |
| 1-day change | +7.53% | -1.01% |
| YTD return | -29.75% | -70.39% |
| 1-year return | -56.63% | -75.80% |
| 5-year return | -99.69% | — |
| EPS (TTM) | $-0.42 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $14.91 |
| 52-week low | $0.38 | $2.49 |
| Distance from 52-week high | -95.24% | -78.89% |
| Average volume | 5.47M | 98.82K |
| Shares outstanding | 43.02M | 12.54M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPHI has outperformed IXHL by 19.2 percentage points over the past year.
CPHI vs IXHL FAQ
Which is bigger, China Pharma or Incannex Healthcare?
Incannex Healthcare (IXHL) is larger, with a market capitalization of $39.49M compared with $39.32M for China Pharma (CPHI).
Which stock has performed better over the past year, CPHI or IXHL?
CPHI returned -56.63% over the past 12 months, compared with -75.80% for IXHL (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Incannex Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.